Helen of Troy finally gave investors a growth quarter last time, and the stock has held onto most of the goodwill. The harder part comes now. The fiscal second-quarter report, due before the open on October 8, needs to show that the first real top-line inflection under the new operating model can survive the loss of easy comparisons. It also needs to show that the first quarter was indeed the low point for tariff-driven margin damage, as management suggested.

The Street is looking for adjusted earnings of $0.51 a share on revenue of about $441.5 million. That revenue figure implies growth of just 2.2% from the year-ago quarter, a sharp step down from the 8.2% gain posted in the first quarter. Part of the slowdown is mechanical. Management said roughly $4 million to $5 million of Prime Day orders landed in the first quarter instead of the second, so a modest headline number would not by itself signal fading demand. Earnings are the more striking comparison. The consensus would be more than double the $0.20 earned a year ago and a big swing from last quarter's loss of $0.08. The whisper number of $0.55 sits slightly above consensus, which suggests some appetite for an upside surprise, though the gap is not large.

For the full year, management held adjusted EPS guidance at $3.25 to $3.75 while nudging revenue up to $1.759 billion to $1.831 billion. Consensus of $3.43 in earnings and $1.78 billion in sales sits in the lower half of both ranges. That tells you analysts believe the sales story more readily than the profit story, and for good reason. Gross margin fell 110 basis points to 46.0% in the first quarter, and adjusted operating margin slipped to 4.0%. The $9.2 million tariff refund now built into guidance is being more than offset by newly flagged inflation in commodities, freight and sourcing costs, along with an unfavorable yuan. The Middle East conflict has made all of these worse. If second-quarter gross margin is still falling at a first-quarter pace, the claim that the worst is over loses credibility. Visible moderation would support the view that the reaffirmed EPS range is achievable rather than a stretch.

The operating details matter as much as the totals. Home and outdoor grew 9.5% last quarter on strength at Osprey and OXO, helped by new distribution at Walmart, Dick's Sporting Goods and Target. Beauty and wellness rose 7%, but that was largely Olive & June and wellness products such as Braun blood pressure monitors, while core beauty brands kept shrinking. Continued share gains in those growth franchises, early traction for OXO's move into pet products, and any stabilization in legacy beauty would show the turnaround is broadening. Management also flagged pricing elasticity running higher than expected in some areas, and further commentary on that would be telling. Cash flow deserves attention too. Free cash flow was slightly negative in the first quarter against a full-year target of $85 million to $100 million, and net leverage of 3.48x leaves the debt-reduction story dependent on cash generation picking up. Details on the hybrid international go-to-market model promised for this fall could also surface.

Sentiment has cooled noticeably, slipping from moderately bullish ahead of the last report to slightly bearish now, even as the stock rose 5.5% since then, roughly double the S&P 500's gain. Shares at $28.15 sit well above the 200-day moving average of $23.02 and in the upper half of the post-earnings range, though still about 8% below the $30.57 high. That is a market cautiously rewarding progress without pricing in a breakout.

The central question is whether Helen of Troy can pair modest sales growth with evidence that margins are turning. Management already guides to a low-single-digit sales decline in the back half, with about $15 million of supply risk embedded. So the credibility of the turnaround now rests less on revenue and more on showing that cost inflation is contained and that the $3.25 to $3.75 earnings range is holding up.